These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24421975)

  • 1. Histopathological change of oral malignant tumour and epithelial dysplasia subjected to photodynamic therapy.
    Uehara M; Ikeda H; Nonaka M; Asahina I
    J Oral Maxillofac Res; 2010; 1(3):e5. PubMed ID: 24421975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.
    Uehara M; Ikeda H; Nonaka M; Sumita Y; Nanashima A; Nonaka T; Asahina I
    Arch Oral Biol; 2011 Nov; 56(11):1366-72. PubMed ID: 21596370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell kinetics of mouse tumour subjected to photodynamic therapy--evaluation by proliferating cell nuclear antigen immunohistochemistry.
    Uehara M; Inokuchi T; Sano K; Sekine J; Ikeda H
    Oral Oncol; 1999 Jan; 35(1):93-7. PubMed ID: 10211316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
    Yu CH; Chen HM; Lin HP; Chiang CP
    J Oral Pathol Med; 2013 Mar; 42(3):257-62. PubMed ID: 22974427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft.
    Togashi H; Uehara M; Ikeda H; Inokuchi T
    Oral Oncol; 2006 May; 42(5):526-32. PubMed ID: 16466960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric analysis of mouse tumor nuclei subjected to photodynamic therapy.
    Uehara M; Sekine J; Wang Z; Inokuchi T
    J Oral Maxillofac Surg; 2005 Feb; 63(2):244-6. PubMed ID: 15690295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
    Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
    Lu EM; Ratnayake J; Rich AM
    BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heat shock protein 47 in the fibrous tissue adjacent to mouse tumour subjected to photodynamic therapy.
    Uehara M; Inokuchi T; Tobita T; Ohba S; Asahina I
    Oral Oncol; 2007 Sep; 43(8):804-10. PubMed ID: 17174144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy.
    Uehara M; Inokuchi T; Sano K; ZuoLin W
    Eur J Cancer; 2001 Nov; 37(16):2111-5. PubMed ID: 11597392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of photodynamic therapy on the morphological changes of periapical inflammation: An experimental study in rats.
    Khan SZ; Karim S; Mirza S
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101839. PubMed ID: 32485402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion.
    Yu CH; Chen HM; Hung HY; Cheng SJ; Tsai T; Chiang CP
    Oral Oncol; 2008 Jun; 44(6):595-600. PubMed ID: 18203648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical 5-ALA mediated photodynamic therapy on proliferation index of keratinocytes in 4-NQO-induced potentially malignant oral lesions.
    Barcessat AR; Huang I; Rosin FP; dos Santos Pinto D; Maria Zezell D; Corrêa L
    J Photochem Photobiol B; 2013 Sep; 126():33-41. PubMed ID: 23892188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G; Lavezzi AM; Biondo B; Pignataro LD
    In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
    Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
    Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM-2 expression differentiates potentially malignant verrucous lesions from oral carcinomas.
    Niranjan KC; Sarathy NA; Alrani D
    Ann Diagn Pathol; 2018 Jun; 34():72-76. PubMed ID: 29661732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression Profiles of GILZ and SGK-1 in Potentially Malignant and Malignant Human Oral Lesions.
    Mozaffari MS; Abdelsayed R
    Front Oral Health; 2021; 2():675288. PubMed ID: 35048019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro sensitivity of oral precancerous and squamous cell carcinoma cell lines to 5-aminolevulinic acid-mediated photodynamic therapy.
    Wang X; Jin J; Li W; Wang Q; Han Y; Liu H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101554. PubMed ID: 31479802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.